Drug intelligence / Profile preview

electrolytes

Development stage
Phase 4
Lead developer
Baxter
Modality
Small Molecules
Administration
Intravenous
01

Overview

Plasmalyt Infusionslösung (marketed internationally as **Plasma-Lyte**) is a balanced, isotonic intravenous crystalloid solution designed to mimic the electrolyte composition and pH of human plasma. Manufactured by **Baxter**, it contains a specific combination of sodium chloride, potassium chloride, magnesium chloride hexahydrate, sodium acetate trihydrate, and sodium gluconate. Unlike traditional 0.9% normal saline, Plasmalyt is physiologically balanced with a pH of approximately 7.4 and an osmolarity of 295 mOsm/L, which helps prevent hyperchloremic metabolic acidosis during large-volume resuscitation. The acetate and gluconate components act as bicarbonate precursors, providing a buffering effect. It is indicated for fluid replacement and electrolyte replenishment in various clinical settings, including surgery, hemorrhagic shock, burns, trauma, and metabolic acidosis. In clinical research, such as Phase 4 trials conducted by **Charité – University Medicine Berlin**, it is frequently used as a standard balanced crystalloid to evaluate hemodynamic stability and acid-base balance in perioperative care.

Brand names
Plasmalyt InfusionslösungPlasma-LytePlasma-Lyte 148Plasma-Lyte148Plasma-Lyte-148Plasma-Lyte APlasma-Lyte 148 (pH 7.4)
Other names
balanced crystalloid solutionisotonic electrolyte solutionmultiple electrolytes injection
02

Targets

ClC (CLC chloride channel family)

Beyond the preview

Go deeper on electrolytes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on electrolytes.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call